Authors: THURLIMANN B CASTIGLIONE M HSUSCHMITZ SF CAVALLI F BONNEFOI H FEY MF MORANT R LOHNERT T GOLDHIRSCH A

Citation: B. Thurlimann et al., FORMESTANE VERSUS MEGESTROL-ACETATE IN POSTMENOPAUSAL BREAST-CANCER PATIENTS AFTER FAILURE OF TAMOXIFEN - A PHASE-III PROSPECTIVE RANDOMIZED CROSS-OVER TRIAL OF 2ND-LINE HORMONAL TREATMENT (SAKK-20 90)/, European journal of cancer, 33(7), 1997, pp. 1017-1024

Authors: THURLIMANN B BERETTA K BACCHI M CASTIGLIONEGERTSCH M GOLDHIRSCH A JUNGI WF CAVALLI F SENN HJ FEY M LOHNERT T

Citation: B. Thurlimann et al., FIRST-LINE FADROZOLE HCI (CGS-16949A) VERSUS TAMOXIFEN IN POSTMENOPAUSAL WOMEN WITH ADVANCED BREAST-CANCER - PROSPECTIVE RANDOMIZED TRIAL OF THE SWISS-GROUP-FOR-CLINICAL-CANCER-RESEARCH SAKK-20 88/, Annals of oncology, 7(5), 1996, pp. 471-479